Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study

BACKGROUND: Minor adverse event following immunizations (AEFIs) are often underreported and self-treated. This study aimed to collect information regarding any and every probable adverse event experienced by the recipient of Covishield vaccine up to 10 days following the first and second dose of vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Velhal, Gajanan D., Kamath, Yash V., Agrawal, Ansh S., Vora, Devanshi S., Dwivedi, Vaibhav R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891042/
https://www.ncbi.nlm.nih.gov/pubmed/36742958
http://dx.doi.org/10.4103/ijcm.ijcm_93_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891042/
https://www.ncbi.nlm.nih.gov/pubmed/36742958
http://dx.doi.org/10.4103/ijcm.ijcm_93_22

Ejemplares similares